NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Huaian Hanyou Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+15 more ↓
77%
Finnrick rating
#215 of 419 Retatrutide vendors
24 of 31 classifiable tests passed
customers 4.2★ (39)
methodology · Purity focus
Finnrick analysis · Retatrutide

Huaian Hanyou's Retatrutide score is held back by late identity failures and a 94.3% purity miss after a long clean streak. The key follow-up is whether those failures cluster by cap or batch description.

methodology →
vendor intelligence report
Vendor Intelligence Report: Huaian Hanyou Peptide

Corporate records and supplier-page claims point to different versions of Huaian Hanyou's history. The report follows a parked plural-domain copycat, a live singular-domain successor, doorway-SEO WhatsApp funnels and a crypto-only adjacent storefront.

36 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
91%
8
2
Tirzepatide
$0.32
77%
8
3
Retatrutideselected
$0.85
77%
31
4
Ipamorelin
$0.65
61%
3
5
Tesamorelin
$1.45
51%
7
6
BPC-157
$0.65
47%
9
7
TB-500
$1.00
35%
5
8
MOTS-c
$0.55
30%
5
9
Cagrilintide
$1.60
-
0
10
CJC-IPA
$0.85
-
0
11
DSIP
$0.80
-
0
12
Epithalon
$0.22
-
0
13
KLOW
$0.28
-
0
14
Melanotan II
$0.45
-
0
15
NAD+
$0.01
-
0
16
Pinealon
$0.55
-
0
17
PT-141
$0.50
-
0
18
Selank
$0.50
-
0
19
Semaglutide
$0.50
-
0
20
Sermorelin
$1.10
-
0
21
SS-31
$0.70
-
0
22
Testosterone
$0.06
-
0
23
VIP
$1.66
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Nov 2025: 72%24 Nov 2025: 72%13 Dec 2025: 73%18 Dec 2025: 75%22 Jan 2026: 77%16 Feb 2026: 80%2 Mar 2026: 80%27 Apr 2026: 82%28 Apr 2026: 83%28 Apr 2026: 84%20 May 2026: 85%27 May 2026: 86%2 Jun 2026: 87%2 Jun 2026: 88%12 Jun 2026: 88%16 Jun 2026: 89%16 Jun 2026: 85%16 Jun 2026: 86%1 Jul 2026: 87%13 Jul 2026: 87%17 Jul 2026: 84%17 Jul 2026: 84%20 Jul 2026: 81%3 Aug 2026: 82%5 Aug 2026: 79%5 Aug 2026: 80%5 Aug 2026: 77%6 Aug 2026: 78%13 Aug 2026: 79%24 Sep 2026: 79%9 Oct 2026: 77%15 Nov 2026: current 77%72%82%77%Nov 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Huaian Hanyou Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Huaian Hanyou Peptide Retatrutide test history
COA-backed lab tests
1-10 of 31

About Huaian Hanyou Peptide test results from Finnrick

Huaian Hanyou Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 76 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Huaian Hanyou Peptide peptides in this dataset are BPC-157 (9 tests), GHK-Cu (8 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 76 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-08-03
Finnrick data entry
During the initial data capture for sample **bg8dm6r**, the declared potency of **KLOW 80 mg** was recorded incorrectly. The value was subsequently reviewed and manually corrected to match the potency reported in the corresponding Certificate of Analysis (COA). As a result of this correction, the sample score was updated from **3.2** to **7.0**.
Peptide testing

Ordered Retatrutide from Huaian Hanyou Peptide? Mail in a sample (US only) and let us test it.

Test my supply